For citations:
Kaleda M.I., Nikishina I.P., Nikolaeva E.V., Shapovalenko A.N., Fedorov E.S., Pachkoria T.N. Rituximab for rheumatic diseases in children: Results of a retrospective study of the safety of therapy. Rheumatology Science and Practice. 2021;59(2):208-214. (In Russ.) https://doi.org/10.47360/1995-4484-2021-208-214
Email this article 